Mediastinal Lymphoma — Trials

Mediastinal Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

141 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 63
Recruiting: 36
Ph III recruiting: 1
Growth YoY: —
Industry share: 22%
Top sponsor: University of Washington
Termination share: 26.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07168486	CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas	enrolling by invitation	Phase 1	15	University of Maryland, BaltimoreOTHER	1	Sep 14, 2026	clinicaltrials
NCT06985576	Long-term Study to Evaluate Safety and Persistence of GF-CART01	enrolling by invitation	—	18	GenomeFrontier Therapeutics TW Co., Ltd.INDUSTRY	1	Jun 11, 2026	clinicaltrials